Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest ‘A’ leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. This recognition solidifies Lupin’s position as a global leader in championing sustainability and transparency. The company’s double ‘A’ rating in Climate and Water is a testament to its commitment to mitigating climate risks, reducing carbon emissions, and ensuring responsible water management throughout its operations.
This achievement represents a substantial improvement from Lupin’s previous ratings, with the company moving from ‘A-‘ in 2024 to ‘A’ in 2025, and from ‘B’ in 2023 to ‘A’ in 2025 for climate and water, respectively. This significant year-over-year progress demonstrates Lupin’s dedication to sustainability and its proactive initiatives aimed at reducing its environmental impact.
Ramesh Swaminathan, Executive Director, Global CFO and Head of API Plus SBU at Lupin, expressed pride in the company’s achievement, stating that Lupin has advanced its efforts to reduce environmental impact through innovation, collaboration, and transparency. He also acknowledged the role of CDP’s strict framework in shaping and accelerating the company’s climate initiatives, fostering ongoing progress.
In addition to the CDP rating, Lupin has also achieved an S&P Global ESG score of 91 in 2025, a best-in-class global achievement that positions the company among a distinguished group of companies worldwide that have surpassed the 90-point threshold. This recognition demonstrates Lupin’s commitment to establishing new sustainability standards and generating lasting value for its communities and the planet. Overall, Lupin’s achievements in sustainability and environmental responsibility underscore its position as a responsible and forward-thinking global pharmaceutical leader.